Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy)

被引:0
作者
Daiana Bezzini
Elisa Gualdani
Matilde Razzanelli
Mario Alberto Battaglia
Rosa Cortese
Paolo Francesconi
Monica Ulivelli
机构
[1] University of Siena,Department of Life Sciences
[2] Agenzia Regionale Di Sanità Della Toscana,Research Department
[3] Italian Multiple Sclerosis Foundation,Department of Medicine, Surgery and Neuroscience
[4] Policlinico Le Scotte,undefined
[5] University of Siena,undefined
来源
Neurological Sciences | 2022年 / 43卷
关键词
Multiple sclerosis; Chronic comorbidities; Prevalence; Administrative data; Sex-related differences; Age-related differences;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:6407 / 6414
页数:7
相关论文
共 102 条
[1]  
Marrie RA(2015)A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview Mult Scler J 21 263-281
[2]  
Cohen J(2009)High frequency of adverse health behaviors in multiple sclerosis Mult Scler Houndmills Basingstoke Engl 15 105-113
[3]  
Stuve O(2010)Emerging effects of comorbidities on multiple sclerosis Lancet Neurol 9 820-828
[4]  
Marrie R(2017)Estimated prevalence of multiple sclerosis in Italy in 2015 Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 38 473-479
[5]  
Horwitz R(2020)Increasing prevalence of multiple sclerosis in Tuscany, Italy Neurol Sci 41 397-402
[6]  
Cutter G(2018)Multiple sclerosis incidence in Tuscany from administrative data Neurol Sci 39 1881-1885
[7]  
Marrie RA(2012)Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia Mult Scler J 18 1310-1319
[8]  
Horwitz RI(2016)Prevalence of multiple sclerosis in Tuscany (Central Italy): a study based on validated administrative data Neuroepidemiol 46 37-42
[9]  
Battaglia MA(2008)Comorbidity, socioeconomic status and multiple sclerosis Mult Scler Houndmills Basingstoke Engl 14 1091-1098
[10]  
Bezzini D(2018)Comorbidity in US patients with multiple sclerosis Patient Relat Outcome Meas 9 97-102